Regional anesthesia

Pulmonary complications after intrathecal morphine administration: a systematic review and meta‐analysis with meta‐regression and trial sequential analysis

AnaesthesiaPublished Systematic review and meta-analysis of randomised trials

Authors' conclusion

There is moderate evidence that intrathecal morphine does not increase rates of sedation or hypoxaemia after non-obstetric surgery. There is very low-quality evidence that intrathecal morphine might increase the rate of respiratory depression.

Study context

Population
Patients undergoing any non-obstetric surgery under GA or spinal anaesthesia
Participants
7,388 patients · 127 trials
Comparison
Intrathecal morphine vs control
Outcome
Rates of postoperative sedation, respiratory depression and hypoxaemia
Methodological detailsmeta-regression, trial sequential analysis
  • Meta-regression
  • Trial sequential analysis

Pooled result

As reported in the abstract

Intrathecal morphine vs ControlOdds ratio (95% CI)P value
Sedation; moderate quality evidence
1.00(0.78–1.28)
P = 0.98
Hypoxaemia; moderate quality evidence
1.22(0.84–1.79)
P = 0.30
Respiratory depression; very low-quality evidence
1.78(1.19–2.67)
P = 0.005

Further pooled results

OutcomeOR (95% CI)P value
Respiratory depression, excluding morphine doses > 500 μg1.49 (0.99–2.23)P = 0.06

Dose–response (meta-regression)

Associations between dose and rate of sedation, respiratory depression and hypoxaemia; not persisting when doses > 500 μg excluded

Trial sequential analysis

Further data may still be required for all outcomes; statistical significance reached for respiratory depression

Original publication

Pulmonary complications after intrathecal morphine administration: a systematic review and meta‐analysis with meta‐regression and trial sequential analysis. Anaesthesia. Published 16 April 2025. doi:10.1111/anae.16606

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.